Ryan Crowe | Vice President, Investor Relations |
Leonard Schleifer | Board Co-Chair, Co-Founder, President and Chief Executive Officer |
George Yancopoulos | Board Co-Chair, Co-Founder, President and Chief Scientific Officer |
Marion McCourt | Executive Vice President and Head of Commercial |
Robert Landry | Executive Vice President and Chief Financial Officer |
Evan Seigerman | BMO Capital Markets |
Tyler Van Buren | TD Cowen |
Mohit Bansal | Wells Fargo |
Tim Anderson | Wolfe Research |
Chris Raymond | Piper Sandler |
Carter Gould | Barclays |
Salveen Richter | Goldman Sachs |
Terence Flynn | Morgan Stanley |
Brian Abrahams | RBC Capital Markets |
Chris Schott | JPMorgan |
Dane Leone | Raymond James |
Colin Bristow | UBS |
Luke Junk | Baird |
David Risinger | Leerink Partners |
Akash Tewari | Jefferies |
Welcome to the Regeneron Pharmaceuticals Second Quarter 2023 Earnings Conference Call. My name is Shannon and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.